AbCellera Biologics (ABCL) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for AbCellera Biologics (ABCL) over the last 6 years, with Q3 2025 value amounting to $223.4 million.
- AbCellera Biologics' Other Gross PP&E Adjustments rose 704.92% to $223.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $223.4 million, marking a year-over-year increase of 704.92%. This contributed to the annual value of $210.3 million for FY2024, which is 3641.28% up from last year.
- Latest data reveals that AbCellera Biologics reported Other Gross PP&E Adjustments of $223.4 million as of Q3 2025, which was up 704.92% from $219.6 million recorded in Q2 2025.
- Over the past 5 years, AbCellera Biologics' Other Gross PP&E Adjustments peaked at $233.8 million during Q2 2024, and registered a low of $31.0 million during Q1 2021.
- In the last 5 years, AbCellera Biologics' Other Gross PP&E Adjustments had a median value of $208.7 million in 2024 and averaged $172.7 million.
- Per our database at Business Quant, AbCellera Biologics' Other Gross PP&E Adjustments surged by 33235.36% in 2021 and then tumbled by 756.65% in 2025.
- AbCellera Biologics' Other Gross PP&E Adjustments (Quarter) stood at $101.6 million in 2021, then soared by 52.39% to $154.9 million in 2022, then fell by 0.47% to $154.2 million in 2023, then skyrocketed by 36.41% to $210.3 million in 2024, then grew by 6.22% to $223.4 million in 2025.
- Its Other Gross PP&E Adjustments was $223.4 million in Q3 2025, compared to $219.6 million in Q2 2025 and $213.7 million in Q1 2025.